Saposin C is a frequent target of paraproteins in Gaucher disease‐associated MGUS/multiple myeloma
暂无分享,去创建一个
[1] M. Dhodapkar,et al. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma. , 2016, The New England journal of medicine.
[2] G. Castaman,et al. Hematological manifestations and complications of Gaucher disease , 2016, Expert review of hematology.
[3] M. Pfreundschuh,et al. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. , 2015, The Journal of clinical investigation.
[4] M. Crescenzi,et al. Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins. , 2014, Human molecular genetics.
[5] C. Hollak,et al. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature , 2013, British journal of haematology.
[6] R. Tamargo,et al. The role of saposin C in Gaucher disease. , 2012, Molecular genetics and metabolism.
[7] C. Vachon,et al. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. , 2012, Blood.
[8] M. Pfreundschuh,et al. Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A. , 2011, Blood.
[9] L. Masuelli,et al. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting. , 2010, Human molecular genetics.
[10] M. Pfreundschuh,et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. , 2009, The Lancet. Oncology.
[11] M. Pfreundschuh,et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS , 2009, International journal of cancer.
[12] G. Grabowski. Phenotype, diagnosis, and treatment of Gaucher's disease , 2008, The Lancet.
[13] M. Pfreundschuh,et al. Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS , 2007, International journal of cancer.
[14] P. Meikle,et al. Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders. , 2000, Clinical chemistry.
[15] N. Tjandra,et al. Solution structure of human GAIP (Galpha interacting protein): a regulator of G protein signaling. , 1999, Journal of molecular biology.
[16] H. Lehrach,et al. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. , 1998, Nucleic acids research.
[17] B. Maras,et al. Structural Analysis of Saposin C and B , 1995, The Journal of Biological Chemistry.
[18] E. Ginns,et al. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). , 1993, Archives of biochemistry and biophysics.
[19] Y. Kishimoto,et al. Saposin proteins: structure, function, and role in human lysosomal storage disorders , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] S. Ueno,et al. Sphingolipid hydrolase activator proteins and their precursors. , 1989, Biochemical and biophysical research communications.